Literature DB >> 21467199

Uterine cysts in female mice deficient for caveolin-1 and insulin-like 3 receptor RXFP2.

Zhen Li1, Shu Feng, Vanessa Lopez, Gina Elhammady, Matthew L Anderson, Elena M Kaftanovskaya, Alexander I Agoulnik.   

Abstract

Gene mutations of insulin-like 3 (INSL3) peptide or its G protein-coupled receptor RXFP2 (relaxin family peptide receptor 2) lead to cryptorchidism. The role of INSL3 in adult females is less known, although INSL3 expression has been described in female reproductive organs. Caveolin-1 (CAV1), the main component of caveoli cell membrane invaginations, has been shown to play an important role in epithelial organization and stromal-epithelial interactions. We created a null allele of Cav1 mice by deleting its second exon through embryonic stem cell targeting. Immunohistochemical analysis demonstrated that CAV1 expression was primarily localized to endothelial blood vessel cells and the myometrium uterus, whereas the strongest expression of Rxfp2 was detected in the endometrial epithelium. By 12 months of age approximately 18% of Cav1-/- females developed single or multiple dilated endometrial cysts lined by a flattened, simple low epithelium. A deficiency for Rxfp2 on Cav1-deficient background led to more than a 2-fold increase in the incidence of uterine cysts (54-58%). Appearance of cysts led to a severe disorganization of uterine morphology. We have found that the cysts had an increased expression of β-catenin and estrogen receptor β in endometrial stromal and epithelial cells and increased epithelial proliferation. An analysis of simple dilated cysts in human patients for CAV1 expression did not show appreciable differences with control regardless of menstrual phase, suggesting an involvement of additional factors in human disease. The results of this study suggest a novel synergistic role of INSL3/RXFP2 and CAV1 in structural maintenance of the uterus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467199      PMCID: PMC3100621          DOI: 10.1210/en.2010-1015

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  48 in total

1.  Relaxin-like factor (RLF) mRNA expression in the fallow deer.

Authors:  S Hombach-Klonisch; J Kauffold; T Rautenberg; K Steger; F Tetens; B Fischer; T Klonisch
Journal:  Mol Cell Endocrinol       Date:  2000-01-25       Impact factor: 4.102

2.  Ligand-independent activation of oestrogen receptor alpha by caveolin-1.

Authors:  A Schlegel; C Wang; R G Pestell; M P Lisanti
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

3.  Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.

Authors:  M Drab; P Verkade; M Elger; M Kasper; M Lohn; B Lauterbach; J Menne; C Lindschau; F Mende; F C Luft; A Schedl; H Haller; T V Kurzchalia
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

4.  A transgenic insertion causing cryptorchidism in mice.

Authors:  P A Overbeek; I P Gorlov; R W Sutherland; J B Houston; W R Harrison; H L Boettger-Tong; C E Bishop; A I Agoulnik
Journal:  Genesis       Date:  2001-05       Impact factor: 2.487

5.  Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas.

Authors:  K Wiechen; C Sers; A Agoulnik; K Arlt; M Dietel; P M Schlag; U Schneider
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

Authors:  B Razani; J A Engelman; X B Wang; W Schubert; X L Zhang; C B Marks; F Macaluso; R G Russell; M Li; R G Pestell; D Di Vizio; H Hou; B Kneitz; G Lagaud; G J Christ; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

7.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

8.  INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent.

Authors:  Jin Kumagai; Sheau Yu Hsu; Hirotaka Matsumi; Jae-Sook Roh; Ping Fu; John D Wade; Ross A D Bathgate; Aaron J W Hsueh
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

9.  Mutations of the GREAT gene cause cryptorchidism.

Authors:  Ivan P Gorlov; Aparna Kamat; Natalia V Bogatcheva; Eric Jones; Dolores J Lamb; Anne Truong; Colin E Bishop; Ken McElreavey; Alexander I Agoulnik
Journal:  Hum Mol Genet       Date:  2002-09-15       Impact factor: 6.150

10.  Relaxin signaling in uterine fibroids.

Authors:  Zhen Li; Jennifer K Burzawa; Anne Troung; Shu Feng; Irina U Agoulnik; Xiaowen Tong; Matthew L Anderson; Ertug Kovanci; Aleksandar Rajkovic; Alexander I Agoulnik
Journal:  Ann N Y Acad Sci       Date:  2009-04       Impact factor: 5.691

View more
  4 in total

1.  Diverse functions of insulin-like 3 peptide.

Authors:  Maria Esteban-Lopez; Alexander I Agoulnik
Journal:  J Endocrinol       Date:  2020-10-01       Impact factor: 4.286

Review 2.  Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compounds.

Authors:  Hooi Hooi Ng; Maria Esteban-Lopez; Alexander I Agoulnik
Journal:  Mol Cell Endocrinol       Date:  2018-12-24       Impact factor: 4.102

3.  Evidence for existence of insulin-like factor 3 (INSL3) hormone-receptor system in the ovarian corpus luteum and extra-ovarian reproductive organs during pregnancy in goats.

Authors:  Ali Mohammed Pitia; Itaru Minagawa; Yasuyuki Abe; Keiichiro Kizaki; Koh-Ichi Hamano; Hiroshi Sasada; Kazuyoshi Hashizume; Tetsuya Kohsaka
Journal:  Cell Tissue Res       Date:  2021-02-15       Impact factor: 5.249

4.  Caveolin-1 Regulation and Function in Mouse Uterus during Early Pregnancy and under Human In Vitro Decidualization.

Authors:  Zhuo Song; Bo Li; Mengyuan Li; Jiamei Luo; Yuqi Hong; Yuying He; Siting Chen; Zhenshan Yang; Chen Liang; Zengming Yang
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.